<?xml version="1.0" ?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" 
 xmlns:mml="http://www.w3.org/1998/Math/MathML">
	<teiHeader>
		<fileDesc xml:id="0"/>
	</teiHeader>
	<text>
		<front/>
		<body/>
		<back>
<listBibl>
	<bibl>. <title level="a">Round Table Discussion. The health and economic impact of rhinitis. Am J Manag ed to participate than those with less severe or better controlled Care</title> <date>1997</date>; <biblScope unit="volume">3</biblScope>: <biblScope unit="page">S8-S18</biblScope> symptoms. Shedden</bibl>
	<bibl>. <author>Juniper EF, Guyatt GH, Dolovich J</author>. <title level="a">Assessment of quality of life in adolescents 19</title>. <author>McFadden EA, Gungor A, Ng B, et al.</author> <title level="a">Loratadine/pseudoephedrine for nasal with allergic rhinoconjunctivitis: development and testing of a questionnaire for symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled clinical trials</title>. <title level="j">J Allergy Clin Immunol</title> <date>1994</date>; <biblScope unit="volume">93</biblScope>: <biblScope unit="page">413-23</biblScope> study. <title level="j">Ear Nose Throat J</title> <date>2000</date>; <biblScope unit="volume">79</biblScope>: <biblScope unit="page">254</biblScope>, <biblScope unit="page">257-8</biblScope>, <note>260 passim</note></bibl>
	<bibl>. <author>Corey JP, Houser SM, Ng BA</author>. <title level="a">Nasal congestion: a review of its etiology, 20. Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene evaluation, and treatment</title>. <title level="j">Ear Nose Throat J</title> <date>2000</date>; <biblScope unit="volume">79</biblScope>: <biblScope unit="page">690-3</biblScope>, <biblScope unit="volume">696</biblScope>, <biblScope unit="page">698</biblScope> <title level="a">passim receptor antagonists compared with other treatments</title>. <title level="j">Ann Allergy Asthma</title></bibl>
	<bibl>. <author>Jessen M, Malm L</author>. <title level="a">Definition, prevalence and development of nasal obstruction</title>. <title level="j">Immunol</title> <date>2003</date>; <biblScope unit="volume">90</biblScope>: <biblScope unit="page">182-90</biblScope> <title level="j">Allergy</title> <date>1997</date>; <biblScope unit="volume">52</biblScope>: <biblScope unit="page">3-6</biblScope></bibl>
	<bibl>. <author>Ratner PH, Paull BR, Findlay SR, et al.</author> <title level="a">Fluticasone propionate given once daily is</title></bibl>
	<bibl>. <author>Ciprandi G, Cirillo I, Vizzaccaro A, et al.</author> <title level="a">Nasal obstruction in patients with as effective for seasonal allergic rhinitis as beclomethasone dipropionate given seasonal allergic rhinitis: relationships between allergic inflammation and nasal twice daily</title>. <title level="j">J Allergy Clin Immunol</title> <date>1992</date>; <biblScope unit="volume">90</biblScope> (<biblScope unit="issue">3</biblScope> <note>Pt 1</note>): <biblScope unit="page">285-91 airflow</biblScope>. <title level="j">Int Arch Allergy Immunol</title> <date>2004</date>; <biblScope unit="volume">134</biblScope>: <biblScope unit="page">34-40</biblScope></bibl>
	<bibl>. <author>Bronsky EA, Dockhorn RJ, Meltzer EO, et al.</author> <title level="a">Fluticasone propionate aqueous</title></bibl>
	<bibl>. <author>Bachert C, van Kempen M, Van Cauwenberge P.</author> <title level="a">Regulation of proinflammatory nasal spray compared with terfenadine tablets in the treatment of seasonal cytokines in seasonal allergic rhinitis</title>. <title level="j">Int Arch Allergy Immunol</title> <date>1999</date>; <biblScope unit="volume">118</biblScope><title level="a">: allergic rhinitis</title>. <title level="j">J Allergy Clin Immunol</title> <date>1996</date>; <biblScope unit="volume">97</biblScope>: <biblScope unit="page">915-21</biblScope></bibl>
	<bibl>. <author>Welch MJ</author>. <title level="a">Topical nasal steroids for allergic rhinitis</title>. <title level="j">West J Med</title> <date>1993</date>; <biblScope unit="volume">158</biblScope>: <biblScope unit="page">616-7</biblScope></bibl>
	<bibl>. <author>Ciprandi G, Cirillo I, Klersy C, et al.</author> <title level="a">Nasal obstruction is the key symptom in hay fever patients</title>. <title level="j">Otolaryngol Head Neck Surg</title> <date>2005</date>; <biblScope unit="volume">133</biblScope>: <biblScope unit="page">429-35</biblScope></bibl>
	<bibl>. <author>Graft D, Aaronson D, Chervinsky P, et al.</author> <title level="a">A placebo-and active-controlled</title></bibl>
	<bibl>. <author>Naclerio R</author>. <title level="a">Clinical manifestations of the release of histamine and other inflam-randomized trial of prophylactic treatment of seasonal allergic rhinitis with matory mediators</title>. <title level="j">J Allergy Clin Immunol</title> <date>1999</date>; <biblScope unit="volume">103</biblScope> (<biblScope unit="issue">3</biblScope> <title level="a">Pt 2): S382-5 mometasone furoate aqueous nasal spray</title>. <title level="j">J Allergy Clin Immunol</title> <date>1996</date>; <biblScope unit="volume">98</biblScope>: <biblScope unit="page">11</biblScope>. <author>Young T, Finn L, Kim H</author>. <title level="a">Nasal obstruction as a risk factor for sleep-disordered 724-31 breathing. The University of Wisconsin Sleep and Respiratory Research Group</title>. 25. <author>Hebert JR, Nolop K, Lutsky BN</author>. <title level="a">Once-daily mometasone furoate aqueous nasal</title> <title level="j">J Allergy Clin Immunol</title> <date>1997</date>; <biblScope unit="volume">99</biblScope>: <biblScope unit="page">S757-62 spray</biblScope> (<note>Nasonex) in seasonal allergic rhinitis: an active-and placebo-controlled</note></bibl>
	<bibl>. <author>McColley SA, Carroll JL, Curtis S, et al.</author> <title level="a">High prevalence of allergic sensitization study</title>. <title level="j">Allergy</title> <date>1996</date>; <biblScope unit="volume">51</biblScope>: <biblScope unit="page">569-76</biblScope> <title level="a">in children with habitual snoring and obstructive sleep apnea</title>. <title level="j">Chest</title> <date>1997</date>; <biblScope unit="volume">111</biblScope>: <biblScope unit="page">26</biblScope>. <author>Mandl M, Nolop K, Lutsky BN</author>. <title level="a">Comparison of once daily mometasone furoate 170-3 (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of</title></bibl>
	<bibl>. <author>Kakumanu S, Glass C, Craig T</author>. <title level="a">Poor sleep and daytime somnolence in allergic perennial rhinitis. 194-079 Study Group</title>. <title level="j">Ann Allergy Asthma Immunol</title> <date>1997</date>; <title level="a">rhinitis: significance of nasal congestion</title>. <title level="j">Am J Respir Med</title> <date>2002</date>; <biblScope unit="volume">1</biblScope>: <biblScope unit="page">195-200</biblScope> <biblScope unit="volume">79</biblScope>: <biblScope unit="page">370-8</biblScope></bibl>
	<bibl>. <author>Caprandi G, Cirillo I, Vizzaccaro A, et al.</author> <title level="a">Airway function and nasal inflammation 27</title>. <author>Craig TJ, Teets S, Lehman EB, et al.</author> <title level="a">Nasal congestion secondary to allergic rhinitis in seasonal allergic rhinitis and asthma</title>. <title level="j">Clin Exp Allergy</title> <date>2004</date>; <biblScope unit="volume">34</biblScope>: <biblScope unit="page">891-6</biblScope> as a cause of sleep disturbance and daytime fatigue and the response to topical</bibl>
	<bibl>. <author>Smolensky MH, Reinberg A, Labrecque G</author>. <title level="a">Twenty-four hour pattern in symptom nasal corticosteroids</title>. <title level="j">J Allergy Clin Immunol</title> <date>1998</date>; <biblScope unit="volume">101</biblScope>: <biblScope unit="page">633-7</biblScope> <title level="a">intensity of viral and allergic rhinitis: treatment implications</title>. <title level="j">J Allergy Clin Immunol</title> <date>1995</date>; <biblScope unit="volume">95</biblScope> (<biblScope unit="issue">5</biblScope> <note>Pt 2</note>): <biblScope unit="page">1084-96</biblScope></bibl>
	<bibl>. <title level="a">Storms WW. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes</title>. <title level="j">Ann Allergy</title></bibl>
	<bibl>. <author>Rappai M, Collop N, Kemp S, et al.</author> <title level="a">The nose and sleep-disordered breathing: what we know and what we do not know</title>. <title level="j">Chest</title> <date>2003</date>; <biblScope unit="volume">124</biblScope>: <biblScope unit="page">2309-23</biblScope></bibl>
	<bibl><title level="j">Asthma Immunol</title> <date>2003</date>; <biblScope unit="volume">91</biblScope>: <biblScope unit="page">131-40</biblScope></bibl>
	<bibl>. <author>Ferguson BJ</author>. <title level="a">Influences of allergic rhinitis on sleep</title>. <title level="j">Otolaryngol Head Neck Surg</title> <date>2004</date>; <biblScope unit="volume">130</biblScope>: <biblScope unit="page">617-29</biblScope> <title level="m">Correspondence and offprints: Arthur Shedden, Schering-Plough Corpora-</title></bibl>
	<bibl>. <author>Flemons WW, Tsai W</author>. <title level="a">Quality of life consequences of sleep-disordered breathing. tion, Kenilworth, 2000 Galloping Hill Road</title>, <pubPlace>NJ 07033, USA</pubPlace>.</bibl>
	<bibl><title level="j">J Allergy Clin Immunol</title> <date>1997</date>; <biblScope unit="volume">99</biblScope>: <biblScope unit="page">S750-6</biblScope></bibl>

		</listBibl>
	</back>
	</text>
</TEI>
